Mark C. Enright
Corporate Officer/Principal bij Imperial College London
Actieve functies van Mark C. Enright
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Imperial College London | Corporate Officer/Principal | 31-10-2011 | - |
Loopbaan van Mark C. Enright
Eerdere bekende functies van Mark C. Enright
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Biocontrol Ltd. (United Kingdom)
 Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | 31-10-2011 | - |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 31-10-2011 | - |
Opleiding van Mark C. Enright
| University of Aberdeen | Doctorate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 4 |
| Verenigde Staten | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Biocontrol Ltd. (United Kingdom)
Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Mark C. Enright
- Ervaring
